Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of RUBCNL mRNA | CTD | PMID:25075043 | 17alpha-ethynylestradiol | affects expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Ethinyl Estradiol affects the expression of RUBCNL mRNA | CTD | PMID:20170705 | 17beta-estradiol | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Estradiol results in increased expression of RUBCNL mRNA | CTD | PMID:21795739 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RUBCNL mRNA | CTD | PMID:32109520 | aflatoxin B1 | decreases methylation | ISO | RUBCNL (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of RUBCNL intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | RUBCNL (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of RUBCNL promoter | CTD | PMID:30157460 | aldehydo-D-glucose | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA | CTD | PMID:37567420 | all-trans-retinoic acid | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RUBCNL mRNA | CTD | PMID:21934132 and PMID:33167477 | alpha-phellandrene | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of RUBCNL mRNA | CTD | PMID:25075043 | antirheumatic drug | decreases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of RUBCNL mRNA | CTD | PMID:24449571 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of RUBCNL mRNA | CTD | PMID:36841081 | benzo[a]pyrene | decreases methylation | ISO | RUBCNL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RUBCNL promoter | CTD | PMID:27901495 | bisphenol A | affects expression | ISO | RUBCNL (Homo sapiens) | 6480464 | bisphenol A affects the expression of RUBCNL mRNA | CTD | PMID:20170705 | bisphenol A | increases methylation | ISO | RUBCNL (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of RUBCNL gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | bisphenol A results in increased expression of RUBCNL mRNA | CTD | PMID:36828454 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RUBCNL mRNA | CTD | PMID:25181051 | buta-1,3-diene | decreases expression | ISO | Rubcnl (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of RUBCNL mRNA | CTD | PMID:29038090 | calcitriol | decreases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of RUBCNL mRNA | CTD | PMID:26485663 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of RUBCNL mRNA | CTD | PMID:27523638 | D-glucose | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA | CTD | PMID:37567420 | dimethylarsinic acid | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA | CTD | PMID:34876320 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RUBCNL mRNA | CTD | PMID:33729688 | dorsomorphin | multiple interactions | ISO | RUBCNL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of RUBCNL mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | entinostat results in increased expression of RUBCNL mRNA | CTD | PMID:27188386 | fructose | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA | CTD | PMID:37567420 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RUBCNL mRNA | CTD | PMID:33387578 | glucose | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA | CTD | PMID:37567420 | mercury atom | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Mercury results in increased expression of RUBCNL mRNA | CTD | PMID:16823088 | mercury(0) | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Mercury results in increased expression of RUBCNL mRNA | CTD | PMID:16823088 | methylarsonic acid | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA | CTD | PMID:34876320 | nickel atom | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Nickel results in increased expression of RUBCNL mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RUBCNL mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RUBCNL mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RUBCNL mRNA | CTD | PMID:33387578 | perfluorooctanoic acid | decreases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of RUBCNL mRNA | CTD | PMID:36326898 | phenylmercury acetate | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of RUBCNL mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RUBCNL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA | CTD | PMID:27188386 | SB 431542 | multiple interactions | ISO | RUBCNL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | affects expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Silicon Dioxide analog affects the expression of RUBCNL mRNA | CTD | PMID:23806026 | silver atom | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Silver results in increased expression of RUBCNL mRNA | CTD | PMID:28959546 | silver(0) | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Silver results in increased expression of RUBCNL mRNA | CTD | PMID:28959546 | sodium arsenate | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | ISO | Rubcnl (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA | CTD | PMID:34876320 | trovafloxacin | decreases expression | ISO | Rubcnl (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of RUBCNL mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RUBCNL mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RUBCNL mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | ISO | RUBCNL (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA | CTD | PMID:27188386 | zearalenone | increases expression | ISO | RUBCNL (Homo sapiens) | 6480464 | Zearalenone results in increased expression of RUBCNL mRNA | CTD | PMID:36828454 | |